October 25, 2024- Baxter recently reported that the company anticipates restarting the highest-throughput IV solutions manufacturing line within the next week, barring any unanticipated developments. Initial batches will be manufactured concurrently with ongoing quality activities and will only be released in accordance with applicable regulatory requirements to ensure the … [Read more...]

October 25, 2024- Abbott has announced a new, first-of-its-kind clinical trial designed to improve outcomes in patients with worsening heart failure who could benefit from advanced therapy options. The TEAM-HF trial, which is planned to enroll up to 850 patients across 75 sites worldwide, will measure pulmonary artery pressures (PAP) using Abbott's CardioMEMS™ HF … [Read more...]

October 25, 2024- Henry Schein, Inc. announced that the Company will present at the following investor conferences in November including the Jefferies London Healthcare Conference on November 19, 2024, at 10:30 a.m. Greenwich Mean Time/5:30 a.m. Eastern Standard Time and Stifel’s Healthcare Conference at Lotte New York Palace Hotel, New York, on November 18, 2024, at 9:45 a.m. … [Read more...]

October 25, 2024- In its latest Pediatric Tech Watch, Vizient, Inc. surveys the impact of artificial intelligence (AI) in healthcare, advancements in pediatric gene therapy and rounds up the latest updates for pediatric immunizations. Read Pediatric Tech Watch. Featured articles in the most recent edition of Pediatric Tech Watch include the impact of AI in pediatric healthcare, … [Read more...]

October 25, 2024- Pfizer Inc. announced that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practice (ACIP) voted to expand its recommendation for the use of certain pneumococcal vaccines, including PREVNAR 20 ® (20-valent Pneumococcal Conjugate Vaccine) for all adults aged 50 and older. This recommendation is pending final … [Read more...]

October 25, 2024- Thermo Fisher Scientific Inc. reported its financial results for the third quarter ended September 28, 2024.Third quarter revenue was $10.60 billion. Third quarter GAAP diluted earnings per share (EPS) was $4.25. Third quarter adjusted EPS was $5.28. Revenue for the quarter was $10.60 billion in 2024 versus $10.57 billion in 2023. Growth in revenue, organic … [Read more...]

October 25, 2024- Join PWH for the 2024 Professional Development Course: “The NeXt Factor - Elevate Your Personal Brand and Professional Presence,” November 1 & 8, from 10 AM – 1:30 PM ET. In this two-session course, develop self-confidence in your leadership abilities by building your unique leadership brand. Learn to elevate your leadership brand to expand your … [Read more...]

October 25, 2024- Viruses never sleep. They move fast and change fast, “which is why we must move faster,” said Abbott. Indeed, ongoing collaboration across the public and private sectors is critical to identify and rapidly respond to global disease outbreaks. No organization, network or country is enough to effectively fight against viral pathogens. The Abbott Pandemic … [Read more...]

October 24, 2024-The Department of Health and Human Services submitted proposed updates to the 20-year-old HIPAA Security Rule to the White House for review, according to Becker's Hospital Review. These updates aim to enhance the cybersecurity protections for electronic health information, GovInfoSecurity reported Oct. 23. The main goal of the proposed changes is to improve … [Read more...]

October 24, 2024- Humana Inc. and Longevity Health, a clinical services company dedicated to serving vulnerable individuals living in a long-term care facility, have announced that eligible residents of long-term care facilities in Indiana, Iowa, Kentucky, Louisiana, New Mexico, Tennessee, Washington, and West Virginia will have access to Humana Together in Health, a Medicare … [Read more...]